Covestor
IMVT icon

Covestor’s Immunovant IMVT Stock Holding History

Covestor’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$54K Sell
1,588
-941
-37% -$37.1K 0.03% 700
2026
Q2 		$97K Sell
2,529
-67
-3% -$2.04K 0.06% 375
2026
Q1 		$64K Buy
2,596
+145
+6% +$3.75K 0.04% 545
2025
Q4 		$63K Sell
2,451
-6,927
-74% -$154K 0.03% 818
2025
Q3 		$152K Buy
9,378
+7,941
+553% +$129K 0.08% 330
2025
Q2 		$23K Sell
1,437
-2,327
-62% -$35.2K 0.01% 1202
2025
Q1 		$64K Buy
3,764
+2,455
+188% +$51.4K 0.04% 737
2024
Q4 		$32K Sell
1,309
-1,515
-54% -$43K 0.02% 1012
2024
Q3 		$80K Buy
2,824
+317
+13% +$9.35K 0.05% 653
2024
Q2 		$66K Buy
2,507
+2,254
+891% +$64.1K 0.04% 727
2024
Q1 		$8K Sell
253
-1
-0.4% -$36 0.01% 1703
2023
Q4 		$11K Buy
254
+245
+2,722% +$9.02K 0.01% 1491
2023
Q3 		$0 Sell
9
-2
-18% -$45 ﹤0.01% 2371
2023
Q2 		$0 Hold
11
– – ﹤0.01% 2366
2023
Q1 		$0 Sell
11
-3
-21% -$52 ﹤0.01% 2280
2022
Q4 		$0 Buy
+14
New +$176 ﹤0.01% 2302

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Covestor's IMVT Position: Q3 2026 in Review

Covestor reduced its Immunovant (IMVT) stake by 37% in Q3 2026, selling an estimated $37.1K and leaving 1,588 shares worth $54K. The position accounts for 0.03% of the portfolio, ranked #700.

Covestor first reported a position in IMVT in Q4 2022 and has held it in 16 quarters since. The position peaked at $152K in Q3 2025. 160 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Covestor held 1,588 shares of Immunovant worth $54K as of Q3 2026.
  • Covestor sold 941 Immunovant shares in Q3 2026, an estimated $37.1K.
  • Immunovant made up 0.03% of Covestor's portfolio in Q3 2026, its #700 holding.
  • Covestor first reported a position in Immunovant in Q4 2022 and has held it in 16 quarters since.
  • Covestor's Immunovant position peaked at $152K in Q3 2025.
  • 160 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.